Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation
Introduction. At present, hemostasis disorders still hold one of the lead places in the pathogenesis of reproductive losses associated with high risk of miscarriage and remain one of the major causes for developing serious obstetric complications. Relevance, efficacy and safety of using drugs contai...
Saved in:
Main Authors: | O. L. Mysik, M. S. Zainulina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-05-01
|
Series: | Акушерство, гинекология и репродукция |
Subjects: | |
Online Access: | https://www.gynecology.su/jour/article/view/967 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HELLP-syndrome as a life-threatening condition: current clinical considerations
by: E. V. Timokhina, et al.
Published: (2019-05-01) -
Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review
by: K. G. Pereverzeva, et al.
Published: (2023-09-01) -
THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01) -
Oral anticoagulants or antiplatelet drugs after heart valve reconstructive surgery: modern guidelines for the practitioners
by: V. P. Kuzmin, et al.
Published: (2024-04-01) -
Imitators of severe preeclampsia: on differential diagnosis and multidisciplinary management
by: A. N. Strizhakov, et al.
Published: (2019-05-01)